Cargando…
Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cells
Glucorticoids (GCs) such as dexamethasone (DEX) remain important treatments for Chronic Lymphocytic Leukemia (CLL) but the mechanisms are poorly understood and resistance is inevitable. Proliferation centers (PC) in lymph nodes and bone marrow offer protection against many cytotoxic drugs and circul...
Autores principales: | Oppermann, Sina, Lam, Avery J., Tung, Stephanie, Shi, Yonghong, McCaw, Lindsay, Wang, Guizhei, Ylanko, Jarkko, Leber, Brian, Andrews, David, Spaner, David E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341931/ https://www.ncbi.nlm.nih.gov/pubmed/27579615 http://dx.doi.org/10.18632/oncotarget.11618 |
Ejemplares similares
-
Persistent janus kinase‐signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trial
por: Spaner, David E., et al.
Publicado: (2019) -
Janus kinases restrain chronic lymphocytic leukemia cells in patients on ibrutinib: Results of a phase II trial
por: Spaner, David E., et al.
Publicado: (2021) -
Low Density Lipoproteins Amplify Cytokine-signaling in Chronic Lymphocytic Leukemia Cells
por: McCaw, Lindsay, et al.
Publicado: (2016) -
A Versatile Cell Death Screening Assay Using Dye-Stained Cells and Multivariate Image Analysis
por: Collins, Tony J., et al.
Publicado: (2015) -
Janus Kinases in Leukemia
por: Raivola, Juuli, et al.
Publicado: (2021)